Sun Pharmaceutical Industries reports 13% rise in Q2 consolidated net profit

02 Nov 2021 Evaluate

Sun Pharmaceutical Industries has reported results for second quarter ended September 30, 2021.

The company has reported over 3-fold jump in its net profit at Rs 809.07 crore for the quarter under review as compared to Rs 223.70 crore for the same quarter in the previous year. Total income of the company increased by 22.49% at Rs 4427.42 crore for Q2FY22 as compared Rs 3614.53 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 12.92% in its net profit at Rs 2047.01 crore for the quarter under review as compared to Rs 1812.79 crore for the same quarter in the previous year. Total income of the company increased by 11.81 % at Rs 9,848.82 crore for Q2FY22 as compared Rs 8808.91 crore for the corresponding quarter previous year. 

Sun Pharma Inds. Share Price

1786.05 -40.05 (-2.19%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.